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Abstract: The expression of lineage molecules (CD13 and CD33), c-Kit receptor (CD117), CD34, HLA-DR and adhesion
molecule CD49d was assessed in acute myeloid leukemia (AML) blast cells from 32 cases, using direct and indirect quantitative
cytometric analysis. High correlation (r=0.8) was found between antigen expression intensity values calculated by direct
analysis method (ABC) and by indirect analysis method (RFI). Moreover, the differences in expression intensity of CD13,
CD117 and CD34 antigens were found between leukemic and normal myeloblasts. This may be helpful in identification of
leukemic cells in the diagnostics of minimal residual disease after treatment in AML patients.
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Introduction
In acute leukemias, abnormalities concern not only
antigen expression but also its intensity, which may have
diagnostic or prognostic significance [3, 5, 6, 8, 12, 14].
Hence, there is a necessity of accurate and reliable
cytometric quantitative evaluation of surface antigen
expression. Special indices were established to calculate
relative "expression intensity" in relation to the type of
cytometer and fluorescence intensity of isotypic control;
an example of such index is so called relative fluores-
cence intensity (RFI) [5, 10]. Moreover, there are special
kits for direct determination of the number of antibody
molecules bound to a corresponding antigenic epitope
which allow to assess capacity of antibody binding by
means of an index called ABC - antibodies bound per
cell [9]. 
Immunophenotypic characteristics of AML myelo-
blasts based on accurate qualitative and quantitative
description of antigens are important for diagnosis. The
literature data show that depending on the type of pro-
liferation (acute or chronic) there are differences in the
density of CD33 antigen on leukemic myeloblasts [7].
Our data show that the density of CD117 (c-Kit receptor)
on bone marrow myeloblasts in AML patients depends
on the number of white blood cells in peripheral blood
[15].
The objective of our study was to perform a quanti-
tative expression analysis of myeloid lineage antigens:
CD13, CD33, CD117 and CD34 that occur on early
blood progenitors and leukemic cells, by two quantita-
tive cytometric methods: direct (ABC) and indirect
(RFI).
Materials and methods
Patients. Bone marrow aspirates were collected from 32 patients
with M1 or M2 adult acute myeloid leukemia. After informed
consent and agreement of the Bioethical Board, 10 bone marrow
aspirates (BM) were obtained from healthy adults serving as control
subjects. AM diagnosis by FAB group criteria was established using
morphological, cytochemical and immunophenotypical examination
of bone marrow smears [1].
Cell preparation and immunofluorescence. Two-ml fresh hepa-
rinized bone marrow aspirates were diluted with an equal volume of
PBS. Cells were incubated with the appropriate monoclonal mouse
anti-human antibodies. Cell surface markers were assessed by direct
immunofluorescence method, using phycoerythrine (PE)-con-
jugated monoclonal antibodies against antigens: CD13, CD33, CD34
and CD117PE (clone 95C3), HLA-DR and CD49d (Becton Dickin-
son, USA). 10 000 cells were counted and data were recorded in the
list mode.
Flow cytometry studies. All samples were analysed using flow
cytometers: CytoronAbsolute with ImmunoCount software (Ortho)
and/or a FACS Calibur with CellQuest software (BD). 
Electronic gating on the basis of FSC and SSC first eliminated
cellular debris and nonviable cells. Distinct cell populations present
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in the specimen were identified using CD45 and SSC. On the
CD45/SSC dot plots, 4 gates were set up for lymphocytes, mono-
cytes, myeloblasts, and granulocytes. To determine the immuno-
phenotype of myeloblasts we used a triple labelling method with
CD45-PE-Cy5 against each CD-FITC and CD-PE. FSC/SSC and
CD45/SSC gating assessed antigen expression on myeloblasts and
the threshold value for antigen positivity was more than 20% positive
blasts.
The receptor expression was measured by an indirect quantifica-
tion method previously described by Miwa et al. [10]. Antigen
expression was quantified by measuring the mean value of PE
fluorescence (in linear scale) of molecules and their isotype control
on AML and normal bone marrow myeloblasts. The distribution of
the fluorescence was always close to a normal Gaussian distribution;
thus the mean value of the fluorescence histogram was a good
representative parameter.
The intensity of antigen expression was found by relative fluores-
cence intensity (RFI) according to the following formula:
RFI = 10 × (3.5 × mean channel of antigen fluorescence ÷ number
of channels) –10 × (3.5 × mean channel of isotype control fluores-
cence ÷ number of channels) [10]
Standardization was performed with fluorescent beads (Dako
fluorospheres).
Direct quantitative analysis were completed by converting fluo-
rescence intensity into the number of antigen molecules per cell, as
measured by antibody binding per cell (ABC). The QuantiBRITE
test (Becton Dickinson) was applied. The mean channels of PE
fluorescence were found and ABC was then calculated, using Quan-
tiCALC software [4].
Statistical analysis. Data are presented as mean ± SD and the
interquartile range. Box-whisker plots illustrate the data distribution.
Significance of differences was assessed by Student’s t-test, using
Statistica software. Differences were considered significant for
p<0.05. Correlation coefficient was determined by linear regression.
Results
Comparison of results of quantitative
expression analysis obtained by two methods:
ABC and RFI
The first quantitative method for the analysis of antigen
expression was the antibody bound per cell (ABC)
method. In the majority of cases, the number of binding
sites (ABC) for myeloid lineage markers CD13 and
CD33 ranged from 1000 to 13000 and for CD117 and
CD34 from 3000 to 20000. The most homogeneous
density on the M1 and M2 leukemic myeloblasts was
shown by adhesion molecule CD49d; in the majority of
cases the number of antibody binding sites ranged from
4000 to 6000. 
The second method of calculation was the relative
fluorescence intensity (RFI) index according to
Miwa’s formula; an indirect method with regard to
isotypic control fluorescence values. Data obtained
using this method showed that the range of RFI values
for CD13 and CD33 was wide, from approximately 8
AU (Arbitrary Units) to 20 AU while for CD117 and
CD34 from 11AU to 22 AU. Detailed data are sum-
marised in Table 1.
If antigen expression intensity was high, it was re-
vealed by both methods (ABC and RFI). Likewise, low
ABC expression intensity values corresponded to low
RFI values. Correlation coefficient between ABC and
RFI values was high: r = 0.7 - 0.8 (Fig. 1).
Comparison of the number of antibody binding
sites (ABC) on leukemic and normal bone
marrow myeloblasts
The ABC and RFI values for CD13 and CD117 on bone
marrow myeloblasts in more than 60% of AML cases
were higher than these found in healthy controls; only in
small subset of AML patients (from 0 to 4%) the values
were lower than those of the controls. 
The pattern of expression intensity presented in ABC
and RFI for CD33 and CD34 antigens was different:
approximately 50% AML cases showed ABC and RFI
values below the lower range for those antigens in
normal myeloblasts. In 4 cases, CD34+ myeloblasts
showed ABC and RFI values above the upper range
value for normal bone marrow myeloblasts (Fig. 2).
Table 1. Comparison of surface molecule expression intensity on AML myeloblasts measured by two quantitative flow cytometry methods:
antibodies bound per cell (ABC) and relative fluorescence intensity (RFI)
Antigens CD13 CD33 CD34 CD117 CD49d
Quantitative metods ABC RFI ABC RFI ABC RFI ABC RFI ABC RFI
AML M1+M2
Mean 7 232 14,8 4 549 12,4 14 607 17,7 10 615 16,5 4 677 13,7
SD 5 684 3,8 3 542 3,3 11 941 3,5 6 163 2,1 2 209 2,1
Min 614 7,1 1 266 6,1 2 059 11,1 3 209 12,5 1 536 9,4
Max 21 117 21,4 12 273 20,0 62 234 24,0 25 349 20,4 11 865 17,3
Normal 
bone marrow 
Mean 3 344 14,1 4 221 14,4 17 846 20,3 4 042 14,1 5 352 14,4
SD 1 178 1,7 2 027 2,0 2 831 1,3 324 1,1 1 176 0,8
Min 1 604 11,9 1 354 10,6 13 986 18,2 3 571 12,2 3 856 13,5
Max 5 184 16,9 7 319 16,7 21 526 21,9 4 492 15,2 7 014 15,5
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Discussion
Comparison of the values of CD13, CD33, CD34 and
CD117 antigen expression intensity, represented as RFI,
and these obtained by the ABC method shows high
positive correlation. Such a correlation suggests that in
the situation when object of interest shows differences
in antigen expression intensity between leukemic blast
cells and the normal bone marrow blast cells, a simple
calculation of RFI index is satisfactory and there is no
need to use reagent kits for the ABC determination. 
In recent years, there is an increasing interest in
applying new methods for the determination of minimal
residual disease (MRD) in patients with AML. The
cytogenetic examination is the most sensitive and re-
liable method, but it is difficult to perform and expens-
ive. Another useful method is determination of detailed
immunophenotype of leukemic myeloblasts with spe-
cific, atypical coexpressions. Unfortunately, in many
cases the immunophenotype of leukemic cells is similar
to that of normal myeloblasts [13]. A comparison of
ABC results of myeloblast antigens, especially CD13,
CD117 and CD34 shows differences in their density
between leukemic and normal myeloblasts. Increase in
CD13 density may be the result of regulatory role of this
molecule in the angiogenesis; this process is unregulated
in AML [2]. The increase in c-Kit receptor (CD117)
density may be related to the changes in adhesive proper-
ties of leukemic myeloblasts leading to leukopenia in
these patients. [11]. 
Fig. 1. Correlation between the values of expression intensity measured using two quantitative methods: ABC and RFI.
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In summary, it has been demonstrated in our study that
determination of expression intensity may be a useful tool
for diagnosis and a specific, individual panel of surface
antigens with special regard to quantitative characteristics
of antigen expression can be evaluated for each patient.
This panel should be further applied to the identification of
leukemic cells in investigation of minimal residual disease.
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